156 related articles for article (PubMed ID: 25862585)
1. Neurofilaments and NFL-TBS.40-63 peptide penetrate oligodendrocytes through clathrin-dependent endocytosis to promote their growth and survival in vitro.
Fressinaud C; Eyer J
Neuroscience; 2015 Jul; 298():42-51. PubMed ID: 25862585
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Fressinaud C; Eyer J
J Neurosci Res; 2014 Feb; 92(2):243-53. PubMed ID: 24327347
[TBL] [Abstract][Full Text] [Related]
3. Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.
Fressinaud C; Thomas O; Umerska AM; Saulnier P
Neurochem Res; 2020 Nov; 45(11):2732-2748. PubMed ID: 32910302
[TBL] [Abstract][Full Text] [Related]
4. The NFL-TBS.40-63 anti-glioblastoma peptide enters selectively in glioma cells by endocytosis.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2013 Oct; 454(2):738-47. PubMed ID: 23603097
[TBL] [Abstract][Full Text] [Related]
5. Axon cytoskeleton proteins specifically modulate oligodendrocyte growth and differentiation in vitro.
Fressinaud C; Berges R; Eyer J
Neurochem Int; 2012 Jan; 60(1):78-90. PubMed ID: 22080155
[TBL] [Abstract][Full Text] [Related]
6. Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
Fressinaud C; Eyer J
Neurochem Int; 2013 Feb; 62(3):306-13. PubMed ID: 23279736
[TBL] [Abstract][Full Text] [Related]
7. Repeated injuries dramatically affect cells of the oligodendrocyte lineage: effects of PDGF and NT-3 in vitro.
Fressinaud C
Glia; 2005 Mar; 49(4):555-66. PubMed ID: 15578728
[TBL] [Abstract][Full Text] [Related]
8. Oligodendrocyte differentiation and signaling after transferrin internalization: a mechanism of action.
Pérez MJ; Fernandez N; Pasquini JM
Exp Neurol; 2013 Oct; 248():262-74. PubMed ID: 23797152
[TBL] [Abstract][Full Text] [Related]
9. The Neurofilament-Derived Peptide NFL-TBS.40-63 Targets Neural Stem Cells and Affects Their Properties.
Lépinoux-Chambaud C; Barreau K; Eyer J
Stem Cells Transl Med; 2016 Jul; 5(7):901-13. PubMed ID: 27177578
[TBL] [Abstract][Full Text] [Related]
10. Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ.
Pendleton JC; Shamblott MJ; Gary DS; Belegu V; Hurtado A; Malone ML; McDonald JW
Exp Neurol; 2013 Sep; 247():113-21. PubMed ID: 23588220
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis.
Hulet SW; Heyliger SO; Powers S; Connor JR
J Neurosci Res; 2000 Jul; 61(1):52-60. PubMed ID: 10861799
[TBL] [Abstract][Full Text] [Related]
12. Investigating the Structural Variability and Binding Modes of the Glioma Targeting NFL-TBS.40-63 Peptide on Tubulin.
Laurin Y; Savarin P; Robert CH; Takahashi M; Eyer J; Prevost C; Sacquin-Mora S
Biochemistry; 2015 Jun; 54(23):3660-9. PubMed ID: 26016807
[TBL] [Abstract][Full Text] [Related]
13. Neural cell adhesion molecule stimulates survival of premyelinating oligodendrocytes via the fibroblast growth factor receptor.
Palser AL; Norman AL; Saffell JL; Reynolds R
J Neurosci Res; 2009 Nov; 87(15):3356-68. PubMed ID: 19739251
[TBL] [Abstract][Full Text] [Related]
14. The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells.
Balzeau J; Pinier M; Berges R; Saulnier P; Benoit JP; Eyer J
Biomaterials; 2013 Apr; 34(13):3381-9. PubMed ID: 23391494
[TBL] [Abstract][Full Text] [Related]
15. Structure-function analysis of the glioma targeting NFL-TBS.40-63 peptide corresponding to the tubulin-binding site on the light neurofilament subunit.
Berges R; Balzeau J; Takahashi M; Prevost C; Eyer J
PLoS One; 2012; 7(11):e49436. PubMed ID: 23152907
[TBL] [Abstract][Full Text] [Related]
16. NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo.
Carradori D; Saulnier P; Préat V; des Rieux A; Eyer J
J Control Release; 2016 Sep; 238():253-262. PubMed ID: 27503706
[TBL] [Abstract][Full Text] [Related]
17. The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells.
Balzeau J; Peterson A; Eyer J
Int J Pharm; 2012 Feb; 423(1):77-83. PubMed ID: 21575694
[TBL] [Abstract][Full Text] [Related]
18. Large-scale generation of highly enriched neural stem-cell-derived oligodendroglial cultures: maturation-dependent differences in insulin-like growth factor-mediated signal transduction.
Broughton SK; Chen H; Riddle A; Kuhn SE; Nagalla S; Roberts CT; Back SA
J Neurochem; 2007 Feb; 100(3):628-38. PubMed ID: 17263792
[TBL] [Abstract][Full Text] [Related]
19. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
[TBL] [Abstract][Full Text] [Related]
20. Media that support the growth and differentiation of oligodendrocytes do not induce olfactory ensheathing cells to express a myelinating phenotype.
Doucette R; Devon R
Glia; 1994 Apr; 10(4):296-310. PubMed ID: 8056440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
